Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall SurvivalYu Sawada, Tetsuya Nakatsura, Daisuke Nobuoka et al.|Clinical Cancer Research|2012Cited by 299
Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cellsToshiaki Yoshikawa, Yuki Kagoya|Cell Reports Medicine|2024Cited by 20